|
Symbol
|
P322TQ | WEVLTQ | WXNLTQ | EOJRCH | RMABXV | YOTLTQ | RMBWDV | RMAVSV | RMAXKV | BTJBKB | ZPRLTQ | OCGRCH | LTHCLK | RMBE8V | AAIETQ | OVCRCH | AAXSTQ | OZURCH | PBVRCH | RMA3QV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Holcim/Amrize Basket / Nestlé S.A. / Novartis AG / Swiss RE AG / Zurich Insurance Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | ABB N / Nestlé N / Novartis N / Roche GS / Swiss RE AG | Nestlé / Novartis | Nestlé / Novartis / Roche GS | Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Geberit AG / Nestlé S.A. / Novartis AG / UBS Group AG / Zurich Insurance Group AG | ABB / Nestlé / Novartis / Roche GS / Zurich | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
23.12.2025 | 31.03.2028 | 30.06.2028 | 14.01.2026 | 12.10.2026 | 24.11.2027 | 27.07.2026 | 23.02.2026 | 23.03.2026 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 09.07.2027 | 13.07.2026 | 19.07.2027 | 09.06.2026 | 13.09.2027 | 07.07.2026 | 21.04.2027 | 09.11.2026 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
294,32 | 11,22 | 179,73 | 287,84 | 65,70 | 63,075 | 63,33 | 47,42 | 59,95 | 43,685 | 42,50 | 58,5776 | 68,832 | 83,70 | 55,033 | 94,0875 | 49,30 | 61,344 | 33,3794 | 28,08 |
| rendement max. p.a. | 95,97% | 5,17% | 6,51% | -0,50% | 9,55% | 6,09% | 4,31% | 80,18% | 3,91% | 3,74% | 3,13% | 4,31% | 5,24% | 20,08% | 1,26% | 23,50% | 2,87% | 4,63% | 4,38% | 7,30% |
| Demande | 98,25 | 100,28 | 94,32 | 100,50 | 95,60 | 95,86 | 100,00 | 79,00 | 100,00 | - | 103,20 | - | - | 91,60 | - | - | 101,44 | 100,37 | - | 97,30 |
| Offre | 99,05 | 101,09 | 95,12 | 101,31 | 96,40 | 96,66 | 101,00 | 86,00 | 101,00 | - | 104,03 | - | - | 92,90 | - | - | 102,25 | 101,18 | - | 98,30 |